MEDXF - Medexus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Medexus Pharmaceuticals's activity chart (see below) currently has 4 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by RAHUL SARUGASER from RAYMOND JAMES on 09-Mar-2023.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Feb-2023

3 years 7 months 10 days ago
(09-Mar-2023)

0/2 (0%)

$2.62 (189.86%)

Buy Since 18-Jun-2021

3 years 8 months 10 days ago
(09-Feb-2023)

0/2 (0%)

$2.29 (61.73%)

Show more analysts

Which analyst most recently updated their price target on MEDXF (Medexus Pharmaceuticals)?

Rahul Sarugaser

Which analyst has the current lower performing score on MEDXF (Medexus Pharmaceuticals) with a proven track record?

TANIA GONSALVES

Which analyst has the most public recommendations on MEDXF (Medexus Pharmaceuticals)?

Rahul Sarugaser works at RAYMOND JAMES and has 8 price targets and 8 ratings on MEDXF

Which analyst is the currently most bullish on MEDXF (Medexus Pharmaceuticals)?

Tania Gonsalves with the highest potential upside of $0

Which analyst is the currently most reserved on MEDXF (Medexus Pharmaceuticals)?

Rahul Sarugaser with the lowest potential downside of -$0